Log in to search using one of your social media accounts:

 

Bronchoscopy Effective for Diagnosis Only Half the Time Bronchoscopy Effective for Diagnosis Only Half the Time
The diagnostic success of bronchoscopy might not be as high as has been believed, new research warns.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 6, 2017 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news

Broncus Medical affiliate acquires Uptake Medical
Uptake Medical said yesterday that its InterVapor device for treating emphysema is back on the market in Europe after its acquisition for an undisclosed amount by an affiliate of Broncus Medical. Broncus set its purchase up under a new entity based in Seattle, Uptake Medical Technology, and plans to add markets in Australia and Asia to its commercial footprint in Europe by the end of the year. The InterVapor device uses heated water vapor to reduce lung volume in emphysema patients. Uptake won an expanded CE Mark in the European Union for InterVapor in August 2015. “2018 promises to be an exciting year for ...
Source: Mass Device - September 8, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Mergers & Acquisitions Respiratory Wall Street Beat Broncus Medical Uptake Medical Source Type: news

A Bloody Bronchoscopy A Bloody Bronchoscopy
Bronchoalveolar lavage fluid in a patient presenting with fever, progressive dyspnea and hemoptysis was blood stained with no evidence of infection. Can you crack the case?Thorax (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 5, 2017 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

An Endoscopic Mask for Fiberoptic Bronchoscopic Intubation An Endoscopic Mask for Fiberoptic Bronchoscopic Intubation
A novel endoscopic mask may be helpful for preventing hypoxia during awake fiberoptic intubation.BMC Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 9, 2017 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Inhalation injury caused by cornstarch dust explosion in intubated patients-a single center experience - Hu HC, Chang CH, Hsu HH, Chang CM, Huang CC, Chuang SS, Kao KC.
This study investigated corr... (Source: SafetyLit)
Source: SafetyLit - August 5, 2017 Category: International Medicine & Public Health Tags: Burns, Electricity, Explosions, Fire, Scalds Source Type: news

Auris Surgical reels in $280m in stealthy Series D round
Auris Surgical Robotics has stealthily raised a massive $280 million in a Series D round of financing, according to the company’s website and an SEC filing posted today. Money in the round came from 39 investors, led by newly invested Coatue Management and joined by Mithril, Lux Capital and Highland Capital Partners, according to the filing and the company’s website. The company is looking to raise an additional $4.9 million before closing the round, with the 1st sale recorded on April 5, according to the SEC filing. Auris Surgical is developing a robotic platform with an initial focus on lung cancer, having wo...
Source: Mass Device - August 4, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Robot-Assisted Surgery Robotics Auris Surgical Robotics Source Type: news

TSO3 files FDA app seeking duodenoscope indication for Sterizone VP4 sterilizer
TSO3 said today it filed a 510(k) application with the FDA as it seeks to clear its Sterizone VP4 sterilizer for the terminal sterilization of duodenoscopes used in endoscopic retrograde cholangio-pancreatography procedures. The company’s Sterizone VP4 is a low-temperature sterilization system which uses dual-sterilants of vaporized hydrogen peroxide and ozone for the terminal sterilization of heat and moisture sensitive medical devices. The system has a single pre-programmed cycle which can be used to sterilize a wide range of devices, the Quebec City-based company said. TSO3 said that if awarded, the approval would...
Source: Mass Device - July 20, 2017 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Regulatory/Compliance Sterilization / Calibration TSO3 Source Type: news

FDA clears Custom Ultrasonics to resume manufacturing System 83 endoscope washer-disinfector
Custom Ultrasonics said yesterday that the FDA inspected and cleared its manufacturing facility in Ivyland, Penn, reinstating the manufacturing, packing and distribution of the company’s System 83 Plus washer and disinfector for use with non-duodenoscope endoscopes. The Philadelphia-based company said that it was required to perform independent validation testing for its System 83 Plus water filtration system and its inline disc filter, which the FDA approved with no changes to the design. New validations were also required for processing bronchoscopes and non-GI endoscopes which all met specified performance cr...
Source: Mass Device - June 27, 2017 Category: Medical Devices Authors: Fink Densford Tags: Endoscopic / Arthroscopic Food & Drug Administration (FDA) Sterilization / Calibration Custom Ultrasonics Source Type: news

Boston Scientific launches Alair asthma treatment in India
Boston Scientific (NYSE:BSX) has launched its Alair bronchial thermoplasty therapy in India, according to an India Blooms report. The device won clearance in the country with indications for treating severe, persistent, drug-resistant asthma in adult patients who’s asthma is not well controlled with inhaled corticosteroids and long acting beta antagonists. Marlborough, Mass.-based Boston Scientific’s Alair bronchial thermoplasty treatment uses a bronchoscope to deliver radiofrequency energy to reduce the amount of excess smooth muscle tissue in the airways. “There are over 18 million estimated a...
Source: Mass Device - June 13, 2017 Category: Medical Devices Authors: Fink Densford Tags: Regulatory/Compliance Respiratory Boston Scientific Source Type: news

Foreign body aspiration in children: a study of children who lived or died following aspiration - Mohammad M, Saleem M, Mahseeri M, Alabdallat I, Alomari A, Za'atreh A, Qudaisat I, Shudifat A, Nasri Alzoubi M.
Foreign body aspiration (FBA) is a preventable cause of mortality and morbidity in children. We conducted a chart review of children who presented to a university hospital due to FBA in the period 1999-2014. Children were either managed with bronchoscopy f... (Source: SafetyLit)
Source: SafetyLit - June 8, 2017 Category: International Medicine & Public Health Tags: Age: Infants and Children Source Type: news

MassDevice.com +5 | The top 5 medtech stories for May 24, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Feds charge ex-Medicare employees with insider trading Former employees at the Centers for Medicare & Medicaid Services used confidential information on Medicare reimbursement changes for radiation treatments and dialysis i...
Source: Mass Device - May 24, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Boston Scientific ’ s post-approval Alair study shows long-term asthma improvement
Patients treated with the Alair device made by Boston Scientific (NYSE:BSX) showed long-term improvement in controlling their asthma, according to a post-approval study released today at the annual meeting of the American Thoracic Society in Washington. The Alair bronchial thermoplasty treatment uses a bronchoscope to deliver radiofrequency energy to reduce the amount of excess smooth muscle tissue in the airways. Boston acquired the technology when it paid $194 million in cash for Asthmatx in 2010, shortly after that company won 510(k) clearance from the FDA for Alair. The deal also included some $250 million in pote...
Source: Mass Device - May 24, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Clinical Trials Respiratory Wall Street Beat Boston Scientific Source Type: news

7 medtech stories we missed this week: May 19, 2017
[Image from unsplash.com]From FDA clearances to touting study data, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. XpandOrtho wins FDA 510(k) clearance XpandOrtho announced in a May 17 press release that it has received FDA 510(k) clearance for its electronic soft tissue balancing instrument for total knee replacement surgery. The sterile-packaged wireless disposable device uses miniature sensors and actuators to balance knee joints during full-range motions. Using constant pressure bellows systems, the device communicates with a display for multiaxial balance and selection of th...
Source: Mass Device - May 19, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Clinical Trials Food & Drug Administration (FDA) Regulatory/Compliance Research & Development Body Vision Medical Exactech Inc. Lombard Medical Technologies MedTech NxThera Inc. Rivanna Medical Visionsense XpandOrtho Source Type: news

Dentistry researcher receives a $2.5M grant to validate liquid biopsy test for lung cancer
In an effort to move the needle forward to improve cancer detection techniques, the National Cancer Institute awarded $2.5 million over a period of five years to principal investigator,Dr. David Wong,  a professor of oral biology and associate dean for research at the UCLA School of Dentistry. The grant will support a clinical trial to validate the research team’s liquid biopsy test, a rapidly emerging technology, with the goal to have it become a certified service at UCLA and beyond.For this project, the dental school is partnering with the UCLA Department of Pathology and Lab Medicine, led by Dr. Scott Binder,...
Source: UCLA Newsroom: Health Sciences - March 30, 2017 Category: Universities & Medical Training Source Type: news

Dilatational Tracheotomy Using the Rigid Endoscope Dilatational Tracheotomy Using the Rigid Endoscope
Is the use of a rigid tracheotomy endoscope a feasible alternative to fiberoptic tracheo-bronchoscopy for dilational tracheotomy?BMC Anesthesiology (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - March 22, 2017 Category: Intensive Care Tags: Anesthesiology Journal Article Source Type: news

Network Modeling Could Optimize End-Stage Emphysema Tx
(MedPage Today) -- Model suggests similar outcomes with surgical, bronchoscopic lung volume reduction (Source: MedPage Today Pulmonary)
Source: MedPage Today Pulmonary - February 10, 2017 Category: Respiratory Medicine Source Type: news

Single-use bronchoscopes appear cost  effective in USA
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - January 31, 2017 Category: Drugs & Pharmacology Source Type: news

My Macgyver Moment
  Since emergency physicians are the MacGyvers of medicine – mullet not included – we asked our readers to send in their best stories of improvising on the fly. What did you do when you were fighting against the clock and couldn’t find the supplies you needed? Here are our four winning entries, with comments by Ken Iserson, MD, author of Improvised Medicine. Published entrants gain free admittance to Blood and Sand, a tropical CME in Atlantis, Bahamas. For a chance to win, send your best MacGyver Moment to lplaster@epmonthly.com Give Me a Hand(stand) by Andrew Langsam I was getting ready to go...
Source: EPMonthly.com - December 31, 2016 Category: Emergency Medicine Authors: Matt McGahen Tags: Uncategorized Source Type: news

Creo Medical looks to raise $25m in UK IPO
U.K.-based electrosurgery device developer Creo Medical said today it looks to raise $25.3 million (UK £20 million) in a U.K. initial public offering, expected to take place on December 9. Creo Medical said it plans to offer shares at approximately 97¢ per share (UK £0.79), while the company has an estimated market capitalization of approximately $77.7 million (UK £61.3 million). The company is developing minimally invasive surgical devices, initially focused on gastrointestinal surgery and lung cancer, using the company’s Croma system which combines bipolar radiofrequency and microwave en...
Source: Mass Device - December 6, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Initial Public Offering (IPO) Surgical Creo Medical Source Type: news

MassDevice.com +5 | The top 5 medtech stories for November 8, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Stanford uses CRISPR to correct sickle cell, human trials planned Researchers from the Stanford University School of Medicine have reportedly used CRISPR, a gene-editing tool, to repair the gene that causes sickle cell disease....
Source: Mass Device - November 8, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Positive 1-month safety results for Medtronic ’ s Navigate bronchoscopy trial
Medtronic (NYSE:MDT) today released 1-month data from the Navigate trial of its superDimension LungGPS system, touting the device as safe and effective based on the preliminary results. A total of 1,289 patients have been enrolled in the trial to date, which spans 37 sites across Europe and North America. The trial looks to evaluate the performance of Fridley, Minn.-based Medtronic’s LungGPS electromagnetic navigation bronchoscopy technology the SuperDimension device uses to navigate the lungs. The initial data comes from 500 procedures, 497 of which were lung lesion biopsies, 91 for fiducial placement and 9 for dye ...
Source: Mass Device - November 8, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Imaging Respiratory Medtronic Source Type: news

First Glimpse of NAVIGATE Bronchoscopy Results Is Promising First Glimpse of NAVIGATE Bronchoscopy Results Is Promising
Interim results from the more than 1200 patient NAVIGATE trial in North America and Europe suggest that electromagnetic navigation bronchoscopy can be safely used to evaluate lung lesions.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 7, 2016 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news

My Macgyver Moment
Since emergency physicians are the MacGyvers of medicine – mullet not included – we asked our readers to send in their best stories of improvising on the fly. What did you do when you were fighting against the clock and couldn’t find the supplies you needed? Here are our four winning entries, with comments by Ken Iserson, MD, author of Improvised Medicine. Published entrants gain free admittance to Blood and Sand, a tropical CME in Atlantis, Bahamas. For a chance to win, send your best MacGyver Moment to lplaster@epmonthly.com Give Me a Hand(stand) by Andrew Langsam I was getting ready to go on a lo...
Source: EPMonthly.com - September 19, 2016 Category: Emergency Medicine Authors: Matt McGahen Tags: Uncategorized Source Type: news

Bronchoscopy
Title: BronchoscopyCategory: Procedures and TestsCreated: 2/8/2000 12:00:00 AMLast Editorial Review: 8/25/2016 12:00:00 AM (Source: MedicineNet Lungs General)
Source: MedicineNet Lungs General - August 25, 2016 Category: Respiratory Medicine Source Type: news

ATS Releases Guidelines for Evaluating Infant Wheeze
(MedPage Today) -- Bronchoscopy, BAL, and 24-hour pH monitoring may be useful (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - August 2, 2016 Category: Pediatrics Source Type: news

Auris Enters Robotic Surgery Market With FDA Nod For Bronchoscope
Auris Surgical Robotics, a California-based startup, has secured FDA approval for a bronchoscope as part of the Auris Robotic Endoscopy System (ARES); it is the company’s first surgical robot cleared for the U.S. market. (Source: Medical Design Online News)
Source: Medical Design Online News - June 10, 2016 Category: Medical Equipment Source Type: news

MassDevice.com +5 | The top 5 medtech stories for June 8, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. FDA releases May 2016 510(k) clearances The Food & Drug Administration released the 510(k) clearances it issued in May 2016. Read more 4. Google’s Verily Star Trek “Tricorder” moonshot flops Verily&r...
Source: Mass Device - June 8, 2016 Category: Medical Equipment Authors: MassDevice Tags: Business/Financial News Plus 5 Source Type: news

FDA clears Ares robot-assisted bronchoscopy device from Auris Surgical Robotics
The FDA last month granted 510(k) clearance to the Ares robot-assisted bronchoscopy platform developed by stealthy Auris Surgical Robotics. San Carlos, Calif.-based Auris was co-founded by medical robotics pioneer Dr. Frederic Moll, who’s behind a slew of other startups in the space, including market leader Intuitive Surgical (NSDQ:ISRG); Mako Surgical, acquired in 2013 for $1.7 billion by Stryker (NYSE:SYK); Restoration Robotics and its Artas hair restoration platform; and Hansen Medical, which Auris agreed to acquire for $80 million in April. Auris revealed in a Septembe...
Source: Mass Device - June 8, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Regulatory/Compliance Respiratory Robot-Assisted Surgery Auris Surgical Robotics Source Type: news

FDA releases May 2016 510(k) clearances
510(K) SUMMARIES OR 510(K) STATEMENTS FOR FINAL DECISIONS RENDERED DURING THE PERIOD May 2016 TOTAL 510(k)s THIS PERIOD 213 TOTAL WITH SUMMARIES 205 TOTAL WITH STATEMENTS 8 May 2016 510(k) Clearances SHARE TWEET LINKEDIN PIN IT EMAIL PRINT 510(K) SUMMARIES OR 510(K) STATEMENTS FOR FINAL DECISIONS RENDERED DURING THE PERIOD May 2016 DEVICE: O-PEP PARI RESPIRATORY EQUIPMENT, INC. 510(k) NO: K150044(Traditional) ATTN: Michael Judge PHONE NO : 1 804 2537274 2412 PARI Way SE DECISION MADE: 27-MAY-16 Midlothian VA 23112 510(k) SUMMARY AVAILABLE FROM FDA ...
Source: Mass Device - June 8, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Regulatory/Compliance Source Type: news

The real costs of clinical research
In 1996 The University of Rochester was offering $150 to volunteers for what was designed to be a minimal-risk research study. To 19-year-old Nicole (Hoiyan) Wan, a hundred and fifty dollars meant being able to afford a trip home to see her parents in Queens, New York. Nicole, like many college students, found the money offered on a campus flier for participation in the clinical research study to be extremely enticing. Back in Queens, New York, Mr. and Mrs. Wan were unaware of their daughter’s intention to enroll in any study. The study was focused on the mechanism by which the lungs defend against infection and poll...
Source: Mass Device - June 7, 2016 Category: Medical Equipment Authors: MassDevice Tags: Blog IMARC Source Type: news

Clinical Software brings precision imaging to pulmonologists.
Built specifically for pulmonary clinician, VIDA|vision™ provides insights to optimize care decisions and improve patient outcomes. Lung Bronchoscopy Planning focuses interventional pulmonologists on planning and performing diagnostic biopsy procedures for peripheral nodule. Lung Volume Reduction provides physicians with information to select appropriate therapy for severe emphysema patients, using evidence-based quantitative CT biomarkers to include heterogeneity and fissure integrity....This story is related to the following:Search for suppliers of: Medical Diagnostic Equipment (Source: Industrial Newsroom - He...
Source: Industrial Newsroom - Health, Medical and Dental Supplies - May 18, 2016 Category: Medical Equipment Source Type: news

Endobronchial Valve Treatment for Severe Emphysema Endobronchial Valve Treatment for Severe Emphysema
Dr Shorr provides a literature update by discussing the STELVIO trial, which tested bronchoscopic endobronchial-valve treatment in patients with severe emphysema without collateral ventilation. Medscape Pulmonary Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 15, 2016 Category: Consumer Health News Tags: Pulmonary Medicine Commentary Source Type: news

MassDevice.com +3 | The top 3 medtech stories for March 10, 2016
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.   3. Visunex Medical wins FDA nod for infant visual imaging system Fremont, Calif-based ophthalmic information system developer Visunex Medical said it won FDA 510(k) clearance for its PanoCam Pro Wide-field Imaging System designed for imaging newborn infants. The PanoCam Pro is a wireless imaging ...
Source: Mass Device - March 10, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 3 Source Type: news

Medtronic’s Navigate lung trial enrolls 1st European patient
Medtronic (NYSE:MDT) said today that it enrolled the 1st European patient in a huge, real-world study of the SuperDimension lung device it acquired along with Covidien early last year. The 2-year, 2,500-patient Navigate trial is designed to evaluate the performance of the LungGPS electromagnetic navigation bronchoscopy technology the SuperDimension device uses to navigate the lungs. The single-arm post-market study also aims to measure how often doctors use the system to obtain biopsies from surrounding lymph nodes and place markers to guide future procedures, Medtronic said. The 1st EU patient in the t...
Source: Mass Device - March 10, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Clinical Trials Imaging Covidien Medtronic Medtronic buys Covidien Pulmonary SuperDimension Inc. Source Type: news

Uptake Medical touts InterVapor study results indicating improved lung function
Uptake Medical said today that data from a study recently published in the journal Lancet indicated that patients who underwent therapy using the company’s InterVapor system experienced statistically significant benefits in both lung function and quality of life. The InterVapor uses heated water vapor to reduce bronchoscopic lung volume in patients with heterogenous upper lobe emphysema, the company said. The results are from the company’s Step-Up randomized, controlled, multi-center, multi-national study designed to evaluate the safety and performance of its Intervapor system. “Non-surgical bronchos...
Source: Mass Device - March 1, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Respiratory Uptake Medical Source Type: news

Modifier 58 vs. Modifier 79; Coding from Fourth-Year Residents
Answers from our coding expert on questions regarding bronchoscopy; modifier 58 vs. modifier 79; and fourth-year residents. (Source: Physicians Practice)
Source: Physicians Practice - January 18, 2016 Category: Practice Management Authors: Bill Dacey Tags: ICD-10 Coding Medical Billing & Collections Source Type: news

Uptake Medical launches InterVapor lung device
Uptake Medical said today it launched a registry trial of its InterVapor system to investigate long-term clinical results in severe emphysema patients. The InterVapor uses heated water vapor to reduce bronchoscopic lung volume in patients with heterogenous upper lobe emphysema, the company said. “Until InterVapor, severe emphysema was typically treated either by requiring patients to undergo highly invasive open surgical lobectomy, or applying foreign material into their lungs. InterVapor offers a less-invasive, bronchoscopic approach that allows clinicians to limit treatment only to the discrete portions of a patien...
Source: Mass Device - January 14, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Oncology Respiratory Uptake Medical Source Type: news

Bronchoscopy-Free Tracheostomy Cost EffectiveBronchoscopy-Free Tracheostomy Cost Effective
Percutaneous dilational tracheostomy (PDT) can be performed successfully with or without the use of bronchoscopy, according to Maryland-based researchers. Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 6, 2016 Category: Surgery Tags: Internal Medicine News Source Type: news

News Quiz: 2015 an Important Year for the LungsNews Quiz: 2015 an Important Year for the Lungs
New drugs for COPD, asthma, and cystic fibrosis made headlines this year. Experts debated the apnea treatment vacuum and what to do about tricky pulmonary fibrosis and contaminated bronchoscopes. Test how well you kept up with the news this year Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 22, 2015 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news

Early CT Screening Is Critical to Reducing Lung Cancer Deaths
Thoracic surgeon and robotics innovator Dr. Farid Gharagozloo believes regular early screenings and better follow-up care will significantly reduce the annual number of Americans dying of lung cancer by almost two-thirds. Gharagozloo, director of cardiothoracic surgery at Florida Hospital Celebration Health, says the medical establishment in the U.S. and patients themselves share the blame for the unreasonably high number of lung cancer deaths today. Patients need to be more assertive. Doctors need to be more aggressive. Together, they can make a big difference. "We can turn this thing around — change the who...
Source: Asbestos and Mesothelioma News - November 10, 2015 Category: Environmental Health Authors: Tim Povtak Tags: Treatment & Doctors Source Type: news

Early Recognition and Management of Inhalational Injury Can be Lifesaving
Medic 13, Engine 13 and Support Car 1301 are dispatched to a local supply company for a chemical spill and a 57-year-old male with trouble breathing. On arrival, the crews are greeted by company officials who report one of the employees was working alone in a small, poorly ventilated back room most of the morning. Another employee went out back to get something and found the man lying on the ground "breathing funny." The crew is handed a material data safety sheet that notes the spilled chemical is 90% sulfuric acid. A decontamination area is set up nearby and the engine company enters the building wearing full p...
Source: JEMS Special Topics - November 2, 2015 Category: Emergency Medicine Authors: Ashley Larrimore, MD Tags: Case of the Month Airway & Respiratory Toxicology Special Topics Patient Care Source Type: news

Early Recognition and Management of Inhalational Injury Can be Lifesaving
Medic 13, Engine 13 and Support Car 1301 are dispatched to a local supply company for a chemical spill and a 57-year-old male with trouble breathing. On arrival, the crews are greeted by company officials who report one of the employees was working alone in a small, poorly ventilated back room most of the morning. Another employee went out back to get something and found the man lying on the ground "breathing funny." The crew is handed a material data safety sheet that notes the spilled chemical is 90% sulfuric acid. A decontamination area is set up nearby and the engine company enters the building wearing full p...
Source: JEMS Patient Care - November 2, 2015 Category: Emergency Medicine Authors: Ashley Larrimore, MD Tags: Case of the Month Airway & Respiratory Toxicology Special Topics Patient Care Source Type: news

Early Recognition and Management of Inhalational Injury Can be Lifesaving
Medic 13, Engine 13 and Support Car 1301 are dispatched to a local supply company for a chemical spill and a 57-year-old male with trouble breathing. On arrival, the crews are greeted by company officials who report one of the employees was working alone in a small, poorly ventilated back room most of the morning. Another employee went out back to get something and found the man lying on the ground "breathing funny." The crew is handed a material data safety sheet that notes the spilled chemical is 90% sulfuric acid. A decontamination area is set up nearby and the engine company enters the building wearing full p...
Source: JEMS Special Topics - November 2, 2015 Category: Emergency Medicine Authors: Ashley Larrimore, MD Tags: Airway & Respiratory Special Topics Patient Care Source Type: news

FDA CDRH issues 2016 regulatory science priorities
The FDA’s Center for Devices and Radiological Health this week released its regulatory science priorities for fiscal year 2016, picking out 10 areas of focus. The priorities will serve to improve safety, effectiveness, performance and quality of medical devices and radiation-emitting products, according to the agency, as well as facilitating the introduction of new devices into the marketplace. “We envision that our external stakeholders can use these priorities to better target their regulatory science resources as well complement these activities. In addition, we believe that collaboratively we can work to ma...
Source: Mass Device - October 19, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Food & Drug Administration (FDA) Regulatory/Compliance Source Type: news

3D printing provides low-cost alternative in bronchoscopy simulation training
3D-printed tracheobronchial tree models compared favorably against other more standard models in training pulmonary physicians to perform bronchoscopy, researchers have found. The study compared the two models based on realism, accuracy, look and feel, and overall usefulness as a teaching tool. Currently, most simulation centers use models that are more expensive than 3-D-printed models and fail to capture the subtle anatomical details of the airways. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 19, 2015 Category: Science Source Type: news

Uptake Medical touts 1st-in-human use of Intervapor lung cancer device
Uptake Medical said it’s InterVapor targeted vapor therapy system has been used in the 1st-ever regional lung cancer tumor ablation procedure. The InterVapor uses heated water vapor to reduce bronchoscopic lung volume in patients with heterogenous upper lobe emphysema, the company said. The patient treated with the system was diagnosed with colorectal cancer that metastasized to the lung. The procedure was performed by Dr. Arschang Valipour at Vienna’s Otto-Wagner-Spital Hospital, Tustin, Calif.-based Uptake said. “InterVapor is the only therapy with the promise of quick, simple, complete bronchoscopic ab...
Source: Mass Device - October 12, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Respiratory Uptake Medical Source Type: news

Uptake Medical Announces First-in-Human Lung Cancer Tumor Ablation Using Intervapor(R) Targeted Vapor Therapy
Clinicians Successfully Isolate, Ablate Lung Tumor via Non-surgical Bronchoscopic Approach TUSTIN, Calif.--(Healthcare Sales & Marketing Network)--Medical technology innovator Uptake Medical announced today that clinicians have successfully performed th... Devices, OncologyUptake Medical, InterVapor, Targeted Vapor Therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 12, 2015 Category: Pharmaceuticals Source Type: news

Medtronic issues new software for SuperDimension lung device
Medtronic (NYSE:MDT) said today it launched the next generation version of its SuperDimension lung navigation system software. The SuperDimension navigation system uses a patients CT scan to generate a 3D virtual bronchial tree which allows operating physicians to map pathways to pulmonary targets during electromagnetic bronchoscopy procedures, the Fridley, Minn.-based company said. “This minimally invasive device helps physicians prepare for the most appropriate therapy depending on the stage of the cancer. Improving chances to more easily identify patients at an early stage may bring a dramatic change in ...
Source: Mass Device - October 8, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Respiratory Software / IT Medtronic Source Type: news

Uptake Medical touts data from InterVapor study
Uptake Medical said today that data from a clinical study of its InterVapor device showed significant improvements in lung function and quality of life in patients treated with the device. The InterVapor uses heated water vapor to reduce bronchoscopic lung volume in patients with heterogenous upper lobe emphysema, the Tustin, Calif.-based company said. “Uptake Medical is pleased with these promising clinical results, which show that InterVapor plays an important role in offering progressive treatment options for emphysema patients. The technology has now been proven in a randomized clinical trial to improve pati...
Source: Mass Device - October 2, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Respiratory Uptake Medical Corp. Source Type: news